会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Assay for Low Molecular Weight Heparin
    • 测定低分子量肝素
    • US20090053754A1
    • 2009-02-26
    • US12103456
    • 2008-04-15
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • C12Q1/02
    • C12Q1/56G01N33/86G01N2405/04
    • A prothrombin time reagent for determination of low molecular weight heparin in fresh whole blood and in anti-coagulant treated blood is provided. The reagent is composed of recombinant animal tissue factor, and a mixture of synthetic phospholipids, which mixture includes a phosphatidylalcohol. A formulation buffer which includes a sensitivity adjuster is used in formulating the reagent. The recombinant animal tissue factor includes rabbit brain. The synthetic phospholipids of the mixture include palmitoyloleoylphosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylserine (POPS), and a phosphatidylalcohol. The phosphatidyl alcohol includes dioleoylphosphatidylethanol, dioleoylphosphatidylmethanol, dioleoylphosphatidylpropanol, dioleoylphosphatidylbutanol, and dioleoylphosphatidylinositol. The sensitivity adjuster included in the formulation buffer is γ-Cyclodextrin. The formulated reagent is air-dried and remains stable for at least 3 weeks at 37° C.
    • 提供了一种用于测定新鲜全血和抗凝血剂处理血液中低分子量肝素的凝血酶原时间试剂。 试剂由重组动物组织因子和合成磷脂的混合物组成,该混合物包含磷脂酰醇。 在配制试剂时使用包含灵敏度调节剂的制剂缓冲液。 重组动物组织因子包括兔脑。 该混合物的合成磷脂包括棕榈酰胆碱磷脂酰胆碱(POPC),棕榈酰叶酰磷脂酰丝氨酸(POPS)和磷脂酰醇。 磷脂酰胆固醇包括二油酰磷脂酰乙醇,二油酰磷脂酰基甲醇,二油酰磷脂酰丙醇,二油酰磷脂酰丁醇和二油酰磷脂酰肌醇。 制剂缓冲液中的灵敏度调节剂是γ-环糊精。 将配制的试剂空气干燥,并在37℃下保持稳定至少3周。
    • 2. 发明授权
    • Volume controlled receptacle
    • 音量控制插座
    • US5836360A
    • 1998-11-17
    • US823973
    • 1997-03-25
    • Michael GavinJames A. Mawhirt
    • Michael GavinJames A. Mawhirt
    • B01L3/00G01F19/00B65B1/04B65B3/04
    • B01L3/508G01F19/00B01L2200/12B01L2400/0406
    • A volume-control receptacle has a reservoir with a bottom. The reservoir is adapted for receiving a fluid. The receptacle has a plurality of capillaries opening on the reservoir at a specific height above the bottom; the capillaries draw off the excess fluid from the receptacle, thereby leaving a specific amount of fluid in the reservoir. In a preferred embodiment, the volume-control receptacle is adapted for use with a disposable cuvette. The reservoir of the receptacle has a drain at the bottom connected to the cuvette for delivering the fluid to a testing instrument or other final application point. The volume-control receptacle has a lip projecting upward from a promontory of the receptacle. A rib extends downward from the lip to the bottom of the reservoir for guiding the fluid into the reservoir.
    • 容积控制容器具有底部的容器。 容器适于接收流体。 容器具有在底部上方的特定高度处在储存器上开口的多个毛细管; 毛细管从容器中排出多余的液体,从而在容器中留下特定量的流体。 在优选实施例中,音量控制插座适于与一次性比色皿一起使用。 容器的储存器在底部具有连接到反应杯的排水口,用于将流体输送到测试仪器或其他最终施加点。 音量控制插座具有从插座的岬向上突出的唇部。 肋条从储存器的唇缘向底部延伸到底部,以将流体引导到储存器中。
    • 3. 发明授权
    • Plastic incision blade
    • 塑料切口刀片
    • US5782852A
    • 1998-07-21
    • US934212
    • 1997-09-19
    • Donald FoggiaAnthony F. Kuklo, Jr.James A. MawhirtGerald Feldman
    • Donald FoggiaAnthony F. Kuklo, Jr.James A. MawhirtGerald Feldman
    • A61B5/15A61B19/00A61D17/32
    • A61B5/15144A61B5/150022A61B5/150427A61B5/150916A61B5/15113A61B5/15117A61B2090/0814
    • An apparatus for implementing a skin incision has an incision blade having at least three facets and at least one sharpened apex. Each of the facets narrows down to one of the apexes. A housing having an exterior surface adapted to be placed flush against the skin and an elongated slot located on the exterior of the surface housing the incision blade. A blade pivoting mechanism located in the housing guides the incision blade through the slot. The blade pivoting mechanism has a first end and second end wherein the first end is pivotally coupled to the housing and the second end supports the incision blade. An actuatable depressing mechanism, located within the housing means, engages and holds the blade pivoting mechanism in a set position, preventing the pivotal movement of the blade pivoting mechanism within the housing. When the depressing mechanism is actuated, the blade pivoting mechanism disengages and transverses the sloped surface, displacing the second end of the blade pivoting mechanism toward the elongated slot, such that the multiple facets of the incision blade emerge from the elongated slot and incise the skin.
    • 用于实施皮肤切口的装置具有至少具有三个小面和至少一个锐化顶点的切割刀片。 每个方面都缩小到其中一个顶点。 具有适于与皮肤相对放置的外表面的壳体和位于容纳切割刀片的表面的外部上的细长槽。 位于壳体中的刀片枢转机构通过狭槽引导切口刀片。 刀片枢转机构具有第一端和第二端,其中第一端枢转地联接到壳体,并且第二端支撑切口刀片。 位于壳体装置内的致动按压机构将刀片枢转机构接合并保持在设定位置,防止刀片枢转机构在壳体内的枢转运动。 当按压机构被致动时,刀片枢转机构脱离并横向倾斜的表面,使刀片枢转机构的第二端朝向细长槽移动,使得切口刀片的多个面从细长的槽中出来并切开皮肤 。
    • 6. 发明授权
    • Apparatus and method for utilizing autotransfusion systems and related
equipment
    • 使用自动补偿系统和相关设备的装置和方法
    • US5055099A
    • 1991-10-08
    • US340773
    • 1989-04-20
    • Michael D. Mintz
    • Michael D. Mintz
    • A61M1/02
    • A61M1/02
    • There is disclosed an autotransfusion system which essentially is contained in a unitary housing section which enables a practitioner to utilize the system in a rapid and efficient manner. The housing section has integrally associated therewith a blood reservoir, which is a major component of an autotransfusion system. The housing has secured thereto a set of instructions which are adapted to be mounted on the arm of an IV pole and which, when positioned on the arm of the IV pole, specifies vertical distances necessary to perform autotransfusion during a blood collection or blood distribution mode. The housing section, as containing the reservoir, with the package and instruction component, is used as a yardstick to establish specified distances in order to control pressure as afforded by gravity. The entire unit lends itself to the rapid installation of an autotransfusion system while providing visual instructions which are integrally associated therewith to provide users with operational guidance that is thereby readily available during an operative procedure. The housing further permits pre-assembly and sterilization of the various components of an autotransfusion system.
    • 8. 发明授权
    • Assay for low molecular weight heparin
    • 测定低分子量肝素
    • US07906299B2
    • 2011-03-15
    • US12103456
    • 2008-04-15
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • C12Q1/56
    • C12Q1/56G01N33/86G01N2405/04
    • A prothrombin time reagent for determination of low molecular weight heparin in fresh whole blood and in anti-coagulant treated blood is provided. The reagent is composed of recombinant animal tissue factor, and a mixture of synthetic phospholipids, which mixture includes a phosphatidylalcohol. A formulation buffer which includes a sensitivity adjuster is used in formulating the reagent. The recombinant animal tissue factor includes rabbit brain. The synthetic phospholipids of the mixture include palmitoyloleoylphosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylserine (POPS), and a phosphatidylalcohol. The phosphatidyl alcohol includes dioleoylphosphatidylethanol, dioleoylphosphatidylmethanol, dioleoylphosphatidylpropanol, dioleoylphosphatidylbutanol, and dioleoylphosphatidylinositol. The sensitivity adjuster included in the formulation buffer is γ-Cyclodextrin. The formulated reagent is air-dried and remains stable for at least 3 weeks at 37° C.
    • 提供了一种用于测定新鲜全血和抗凝血剂处理血液中低分子量肝素的凝血酶原时间试剂。 试剂由重组动物组织因子和合成磷脂的混合物组成,该混合物包含磷脂酰醇。 在配制试剂时使用包含灵敏度调节剂的制剂缓冲液。 重组动物组织因子包括兔脑。 该混合物的合成磷脂包括棕榈酰胆碱磷脂酰胆碱(POPC),棕榈酰叶酰磷脂酰丝氨酸(POPS)和磷脂酰醇。 磷脂酰胆固醇包括二油酰磷脂酰乙醇,二油酰磷脂酰基甲醇,二油酰磷脂酰丙醇,二油酰磷脂酰丁醇和二油酰磷脂酰肌醇。 制剂缓冲液中的灵敏度调节剂是γ-环糊精。 将配制的试剂空气干燥,并在37℃下保持稳定至少3周。
    • 9. 发明授权
    • Assay for low molecular weight heparin
    • 测定低分子量肝素
    • US07358337B2
    • 2008-04-15
    • US10222345
    • 2002-08-16
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • Ted C. K. LeeAmanda B. McBrideFrank M. LaDuca
    • A61K35/14
    • C12Q1/56G01N33/86G01N2405/04
    • A prothrombin time reagent for determination of low molecular weight heparin in frsh whole blood and in anti-coagulant treated blood is provided. The reagent is composed of recombinant animal tissue factor, and a mixture of synthetic phospholipids, which mixture includes a phosphatidylalcohol. A formulation buffer which includes a sensitivity adjuster is used in formulating the reagent. The recombinant animal tissue factor includes rabbit brain. The synthetic phospholipids of the mixture include palmitoyloleoylphosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylserine (POPS), and a phosphatidylalcohol. The phosphatidyl alcohol includes dioleoylphosphatidylethanol, dioleoylphosphatidylmethanol, dioleoylphosphatidylpropanol, dioleoylphosphatidylbutanol, and dioleoylphosphatidylinositol. The sensitivity adjuster included in the formulation buffer is γ-Cyclodextrin. The formulated reagent is air-dried and remains stable for at least 3 weeks at 37° C.
    • 提供了一种凝血酶原时间试剂,用于测定全血和抗凝血剂处理的血液中的低分子肝素。 试剂由重组动物组织因子和合成磷脂的混合物组成,该混合物包含磷脂酰醇。 在配制试剂时使用包含灵敏度调节剂的制剂缓冲液。 重组动物组织因子包括兔脑。 该混合物的合成磷脂包括棕榈酰胆碱磷脂酰胆碱(POPC),棕榈酰叶酰磷脂酰丝氨酸(POPS)和磷脂酰醇。 磷脂酰胆固醇包括二油酰磷脂酰乙醇,二油酰磷脂酰基甲醇,二油酰磷脂酰丙醇,二油酰磷脂酰丁醇和二油酰磷脂酰肌醇。 制剂缓冲液中的灵敏度调节剂是γ-环糊精。 将配制的试剂空气干燥,并在37℃下保持稳定至少3周。
    • 10. 发明授权
    • Adjustable skin incision device
    • 可调皮肤切开装置
    • US5797940A
    • 1998-08-25
    • US866172
    • 1997-05-30
    • James A. MawhirtNikki S. Thompson
    • James A. MawhirtNikki S. Thompson
    • A61B17/32
    • A61B17/32093A61B5/150022A61B5/15019A61B5/150259A61B5/150427A61B5/150916A61B5/15113A61B5/15128A61B5/15144
    • A device for making an adjustably sized incision in skin. The device comprises a housing having a slotted opening; a blade disposed within the housing for making an incision in skin; a blade triggering mechanism disposed within the housing, for propelling the blade through the slotted opening of the housing a given distance to make an incision of a predetermined size in the skin; and incision size adjusting mechanism associated with the housing for selectively adjusting the size of the incision. The incision size adjusting mechanism includes a cam disposed within the housing, the cam being manually movable relative to the housing for allowing the size of the incision to be adjusted by variably limiting the given distance the blade is propelled through the slotted opening of the housing according to the cam's position relative to the housing. In one embodiment, the cam adjusts the size of the incision by varying the incision's depth into the skin to produce blood sample volumes which are selectively increased or decreased according to a selected depth of the incision. This feature makes the device especially suitable for making skin incisions in adults or children. In another embodiment, the cam adjusts the size of the incision by varying the incision's depth into the skin and the incision's length in the skin to produce blood sample volumes which are selectively increased or decreased according to a selected depth and length of the incision. This feature makes the device especially suitable for making skin incisions in infants and toddlers.
    • 用于在皮肤中制作可调节尺寸的切口的装置。 该装置包括具有开槽开口的壳体; 设置在所述壳体内用于在皮肤中形成切口的刀片; 刀片触发机构,其设置在所述壳体内,用于通过所述壳体的开槽开口推动所述刀片给定距离以在皮肤中切割预定尺寸; 以及与壳体相关联的切口尺寸调节机构,用于选择性地调节切口的尺寸。 所述切口尺寸调节机构包括设置在所述壳体内的凸轮,所述凸轮可手动地相对于所述壳体移动,以允许通过可变地限制所述刀片通过所述壳体的开槽开口被推进的给定距离来调节所述切口的尺寸, 到凸轮相对于壳体的位置。 在一个实施例中,凸轮通过改变切口进入皮肤的深度来调节切口的尺寸,以产生根据切口的选定深度选择性地增加或减少的血液样本体积。 该功能使得该装置特别适合于在成人或儿童中进行皮肤切口。 在另一个实施例中,凸轮通过改变切口在皮肤中的深度和皮肤中的切口长度来调节切口的尺寸,以产生根据切口的所选深度和长度选择性地增加或减少的血液样本体积。 该特征使得该装置特别适用于在婴儿和幼儿中进行皮肤切口。